Progress on Therapy of Breast Cancer with Vitamin Q10 and the Regression of Metastases
 
   

Progress on Therapy of Breast Cancer
with Vitamin Q10 and the
Regression of Metastases

This section is compiled by Frank M. Painter, D.C.
Send all comments or additions to:
   Frankp@chiro.org
 
   

FROM:   Biochem Biophys Res Commun 1995 (Jul 6);   212 (1):   172177

Lockwood K, Moesgaard S, Yamamoto T, Folkers K

Pharma Nord,
Vejle, Denmark


Over 35 years, data and knowledge have internationally evolved from biochemical, biomedical and clinical research on vitamin Q10 (coenzyme Q10; CoQ10) and cancer, which led in 1993 to overt complete regression of the tumors in two cases of breast cancer. Continuing this research, three additional breast cancer patients also underwent a conventional protocol of therapy which included a daily oral dosage of 390 mg of vitamin Q10 (Bio-Quinone of Pharma Nord) during the complete trials over 3-5 years. The numerous metastases in the liver of a 44-year-old patient "disappeared," and no signs of metastases were found elsewhere. A 49-year-old patient, on a dosage of 390 mg of vitamin Q10, revealed no signs of tumor in the pleural cavity after six months, and her condition was excellent. A 75-year-old patient with carcinoma in one breast, after lumpectomy and 390 mg of CoQ10, showed no cancer in the tumor bed or metastases. Control blood levels of CoQ10 of 0.83-0.97 and of 0.62 micrograms/ml increased to 3.34-3.64 and to 3.77 micrograms/ml, respectively, on therapy with CoQ10 for patients A-MRH and EEL.


Return to the Co-Q10 Page

Since 8-19-2001

         © 19952017 ~ The Chiropractic Resource Organization ~ All Rights Reserved